Recent Updates
Recently added Catalysts
RLAY Positive Sentiment

Relay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Thursday, February 1, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Relay Therapeutics will participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on February 8, 2024. The management will conduct a fireside chat that can be accessed via a live webcast from their website. An archived version of the presentation will be available for 30 days after the event, showcasing the company's advancements in drug discovery.
Price reaction · baseline $9.25 (2024-01-31 close) · hit after-hours · clean, no other RLAY news in the window
day 0 close · peak
-1.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Relay Therapeutics is engaging in significant industry events.
  • Participation at the Guggenheim Healthcare Talks highlights the company's visibility.
  • The event provides an opportunity for Relay to showcase its innovative technologies.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+284%
120-day peak, hindsight
Typical move
11.8%
average across 6 past catalysts
Cash runway
~50 mo
Minimal dilution risk
Lead asset
RLY-8161
Phase 1 · Advanced NRAS-Mutant Melanoma

Full Press Release Details

CAMBRIDGE, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that management will participate in a fireside chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on Thursday, February 8, 2024 at 10:30 a.m. ET.
The presentation will be webcast live and may be accessed through Relay Therapeutics’ website under Events in the News & Events section through the following link: https://ir.relaytx.com/news-events/events-presentations. An archived replay of the webcast will be available for up to 30 days following the event.
About Relay Therapeutics

Frequently Asked Questions

When is Relay Therapeutics' fireside chat scheduled?

The fireside chat is on February 8, 2024, at 10:30 a.m. ET.

Where can I watch the Relay Therapeutics presentation?

The presentation can be accessed on their website under Events.

Will the presentation be available after the live event?

Yes, an archived replay will be available for 30 days post-event.

What is Relay Therapeutics focused on?

Relay Therapeutics specializes in precision medicine and drug discovery.

ShareAdd on Google
Tags: RLAY Viatris Investor Conferences Healthcare Relay Therapeutics biotechnology conference Guggenheim Healthcare Talks precision medicine
Last updated: Feb 1, 2024

Biotech snapshot

Cash runway
$911M liquidity · $18M/mo burn
~50 mo
Minimal dilution risk
Lead asset
RLY-8161Phase 1
Advanced NRAS-Mutant Melanoma →

Catalyst track record

+284%
best trade around RLAY's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for RLAY.

See every catalyst's timing & PoA →